Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Krag, MPerner, A
Wetterslev, J
Wise, M P
Borthwick, M
Bendel, S
McArthur, C
Cook, D
Nielsen, N
Pelosi, P
Keus, F
Guttormsen, A B
Moller, A D
Møller, M H
Issue Date
2015-05
Metadata
Show full item recordCitation
Acta Anaesthesiol Scand. 2015, 59 (5):576-85Abstract
Stress ulcer prophylaxis (SUP) may decrease the incidence of gastrointestinal bleeding in patients in the intensive care unit (ICU), but the risk of infection may be increased. In this study, we aimed to describe SUP practices in adult ICUs. We hypothesised that patient selection for SUP varies both within and between countries.Adult ICUs were invited to participate in the survey. We registered country, type of hospital, type and size of ICU, preferred SUP agent, presence of local guideline, reported indications for SUP, criteria for discontinuing SUP, and concerns about adverse effects. Fisher's exact test was used to assess differences between groups.
Ninety-seven adult ICUs in 11 countries participated (eight European). All but one ICU used SUP, and 64% (62/97) reported having a guideline for the use of SUP. Proton pump inhibitors were the most common SUP agent, used in 66% of ICUs (64/97), and H2-receptor antagonists were used 31% (30/97) of the units. Twenty-three different indications for SUP were reported, the most frequent being mechanical ventilation. All patients were prescribed SUP in 26% (25/97) of the ICUs. Adequate enteral feeding was the most frequent reason for discontinuing SUP, but 19% (18/97) continued SUP upon ICU discharge. The majority expressed concern about nosocomial pneumonia and Clostridium difficile infection with the use of SUP.
In this international survey, most participating ICUs reported using SUP, primarily proton pump inhibitors, but many did not have a guideline; indications varied considerably and concern existed about infectious complications.
Description
To access publisher's full text version of this article click on the hyperlink at the bottom of the pageAdditional Links
http://dx.doi.org/ 10.1111/aas.12508http://onlinelibrary.wiley.com/doi/10.1111/aas.12508/epdf
Rights
Archived with thanks to Acta anaesthesiologica Scandinavicaae974a485f413a2113503eed53cd6c53
10.1111/aas.12508
Scopus Count
Collections
Related articles
- An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
- Authors: Tasaka CL, Burg C, VanOsdol SJ, Bekeart L, Anglemyer A, Tsourounis C, Rennke S
- Issue date: 2014 Apr
- Inappropriate continuation of stress ulcer prophylaxis beyond the intensive care setting.
- Authors: Farley KJ, Barned KL, Crozier TM
- Issue date: 2013 Jun
- Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units.
- Authors: Eastwood GM, Litton E, Bellomo R, Bailey MJ, Festa M, Beasley RW, Young PJ
- Issue date: 2014 Sep
- Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
- Authors: Krag M, Perner A, Wetterslev J, Møller MH
- Issue date: 2013 Aug
- Stress ulcer prophylaxis in critical illness: a Canadian survey.
- Authors: Shears M, Alhazzani W, Marshall JC, Muscedere J, Hall R, English SW, Dodek PM, Lauzier F, Kanji S, Duffett M, Barletta J, Alshahrani M, Arabi Y, Deane A, Cook DJ
- Issue date: 2016 Jun